Grant: Discovery Grants Program - Individual
University of Toronto
$48,000.00
The immunobiology of chemokine receptor CCR5
EF 2011-12
Résumé
Our immune response to virus infection, or cancer, or a chronic autoimmune disease such as arthritis, includes a family of factors, called 'chemokines,' that trigger cells to respond to the disease onslaught. For many years it was known that chemokines orchestrate the trafficking of immune cells to sites of infection, inflammation, or tumors, to provide the appropriate response. Using NSERC funding we have accumulated data that show that chemokines will trigger specific factors - receptors - on the surface of responsive cells, to activate signals that create additional biological responses: cell death, cancer cell proliferation and, most recently we have shown that this receptor, once activated, will also alter the energy status of the cell. This is very important in the context of cancers, since increased energy leads to increased growth and invasion of surrounding tissues. In continuing studies we plan to examine this regulation of energy by this receptor activation, to (1) develop strategies where we could enhance the energy status to promote cell trafficking, in cases where immune cells are required to suppress inflammation, and (2) inhibit the energy status of a cancer cell to block cancer progression. Notably, in other NSERC funded studies we have shown that this receptor is also required for infection with a virus - not as a means to enter cells, but to activate signals within the cell that will create a hospitable environment for the virus. Our future studies are directed at identifying the factors within cells that the virus and the receptor bind with to create this hospitable environment, again as a strategy to develop antiviral drugs that may have utility in many virus infections.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
326965-2011
Name nom
Fish, Eleanor
Department département
Immunology
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2011
Award amount
48000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
5100
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell biology
Research subject fr
Biologie cellulaire
Partie
1
Nb partie
5
Application title
The immunobiology of chemokine receptor CCR5
Keyword
NSERC
Application summary
Our immune response to virus infection, or cancer, or a chronic autoimmune disease such as arthritis, includes a family of factors, called 'chemokines,' that trigger cells to respond to the disease onslaught. For many years it was known that chemokines orchestrate the trafficking of immune cells to sites of infection, inflammation, or tumors, to provide the appropriate response. Using NSERC funding we have accumulated data that show that chemokines will trigger specific factors - receptors - on the surface of responsive cells, to activate signals that create additional biological responses: cell death, cancer cell proliferation and, most recently we have shown that this receptor, once activated, will also alter the energy status of the cell. This is very important in the context of cancers, since increased energy leads to increased growth and invasion of surrounding tissues. In continuing studies we plan to examine this regulation of energy by this receptor activation, to (1) develop strategies where we could enhance the energy status to promote cell trafficking, in cases where immune cells are required to suppress inflammation, and (2) inhibit the energy status of a cancer cell to block cancer progression. Notably, in other NSERC funded studies we have shown that this receptor is also required for infection with a virus - not as a means to enter cells, but to activate signals within the cell that will create a hospitable environment for the virus. Our future studies are directed at identifying the factors within cells that the virus and the receptor bind with to create this hospitable environment, again as a strategy to develop antiviral drugs that may have utility in many virus infections.